SCHEMBL327686

SCHEMBL327686

CC1CCN(C(c2ccc(Cl)cc2)c2nnn[nH]2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.43
CYP19A1 P11511 1/20 0.43
SIGMAR1 Q99720 4/20 0.43
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
TSHR P16473 6/20 0.41
ALDH1A1 P00352 5/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
NPSR1 Q6W5P4 8/20 0.41
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
BCL2 P10415 1/20 0.40
CHRM1 P11229 1/20 0.40
DRD1 P21728 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL323778 0.84 CHRM2 (0.58) CYP2D6CYP19A1MEN1KMT2ATSHR
SCHEMBL12503222 0.83 CYP2D6 (0.47) CYP2D6CYP19A1MEN1KMT2ATSHR
SCHEMBL324172 0.82 CYP2D6 (0.67) CYP2D6CYP19A1SIGMAR1MEN1KMT2A
SCHEMBL325002 0.81 ALDH1A1 (0.47) CYP2D6CYP19A1MEN1KMT2ATSHR
SCHEMBL323141 0.79 SLC6A9 (0.38) CYP2D6CYP19A1TSHRKDM4ENPSR1
SCHEMBL323776 0.79 CYP3A4 (0.61) CYP2D6CYP19A1TSHRALDH1A1NPSR1
SCHEMBL325153 0.78 CYP3A4 (0.48) CYP2D6CYP19A1TSHRALDH1A1MAPT
SCHEMBL324763 0.74 CYP3A4 (0.45) CYP2D6CYP19A1TSHRALDH1A1KDM4E
SCHEMBL324760 0.69 ALDH1A1 (0.45) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL1281621 0.68 MEN1 (0.65) CYP2D6CYP19A1MEN1KMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590953-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2013-05-15 EP claimed
WO-2012004604-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-01-12 WO claimed
EP-2590953-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2013-05-15 EP disclosed
WO-2012004604-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-01-12 WO disclosed